Delving into the Latest Updates on Recombinant GLP-1-Fc fusion protein(Genekey Biotech (Chengdu) ) with Synapse

[Translation] A single-center, randomized, open-label, parallel-controlled phase I clinical study comparing the pharmacokinetic characteristics, safety and immunogenicity of recombinant glucagon-like peptide-1-Fc fusion protein injection (SAL015) and dulaglutide injection (Duida®) in healthy Chinese male subjects

主要目的：比较SAL015和度易达®在中国健康男性受试者中单次皮下注射后药代动力学特征的相似性。次要目的：比较SAL015和度易达®在中国健康男性受试者中单次皮下注射后安全性和免疫原性的相似性。

[Translation]

Primary objective: To compare the similarity of pharmacokinetic characteristics of SAL015 and Duyida® in healthy Chinese male subjects after a single subcutaneous injection. Secondary objective: To compare the similarity of safety and immunogenicity of SAL015 and Duyida® in healthy Chinese male subjects after a single subcutaneous injection.

Start Date06 Nov 2020

Sponsor / Collaborator

Genekey Biotech (Chengdu) Co. Ltd.

[+1]

100 Clinical Results associated with Recombinant GLP-1-Fc fusion protein(Genekey Biotech (Chengdu) )

Login to view more data

100 Translational Medicine associated with Recombinant GLP-1-Fc fusion protein(Genekey Biotech (Chengdu) )

Login to view more data

100 Patents (Medical) associated with Recombinant GLP-1-Fc fusion protein(Genekey Biotech (Chengdu) )

Login to view more data

100 Deals associated with Recombinant GLP-1-Fc fusion protein(Genekey Biotech (Chengdu) )

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Diabetes Mellitus	Phase 3	China	Shenzhen Salubris Pharmaceuticals Co., Ltd.	21 Jul 2022
Diabetes Mellitus, Type 2	Phase 1	China	Salubris (Suzhou) Pharmaceuticals Co., Ltd.	06 Nov 2020
Diabetes Mellitus, Type 2	Phase 1	China	Genekey Biotech (Chengdu) Co. Ltd.	06 Nov 2020
Obesity	IND Application	China	Shenzhen Salubris Pharmaceuticals Co., Ltd.	04 Apr 2018

Login to view more data

Clinical Result

Indication

Phase

Evaluation

View All Results

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.

login

or

view full example data

Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.

login

or

view full example data

Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.

login

or

view full example data

Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.

login

or

view full example data

Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.

login

or

view full example data

Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

login

or

view full example data